04/16/2024
3:30 PM | Clearside Biomedical (Issuer)
Gibney Anthony S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
3:31 PM | Clearside Biomedical (Issuer)
Gibney Anthony S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
6:15 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:30 PM | Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:20 PM | Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:19 PM | Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2024
4:15 PM | Clearside Biomedical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/12/2024
3:16 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
12:00 PM | Clearside Biomedical (Issuer)
WHITMORE BRADFORD T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:05 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
5:25 PM | Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:26 PM | Clearside Biomedical (Issuer)
LASEZKAY GEORGE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
2:26 PM | Clearside Biomedical (Subject)
LASEZKAY GEORGE M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
2:04 PM | Clearside Biomedical (Subject)
Deignan Charles A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
3:10 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:30 PM | Clearside Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
11:01 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:24 PM | Clearside Biomedical (Issuer)
WHITMORE BRADFORD T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
4:06 PM | Clearside Biomedical (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:46 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:34 PM | Clearside Biomedical (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:35 PM | Clearside Biomedical (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:29 PM | Clearside Biomedical (Issuer)
LASEZKAY GEORGE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:30 PM | Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
5:55 PM | Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
3:31 PM | Clearside Biomedical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/23/2023
3:37 PM | Clearside Biomedical (Issuer)
SHAFFER CHRISTY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Clearside Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Clearside Biomedical (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Clearside Biomedical (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:39 PM | Clearside Biomedical (Issuer)
EDWARDS JEFFREY L (Reporting)
EDWARDS JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:40 PM | Clearside Biomedical (Issuer)
Clearside Biomedical (Issuer)
Croarkin Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:41 PM | Clearside Biomedical (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:36 PM | Clearside Biomedical (Issuer)
YERXA BENJAMIN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:15 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2023
11:15 PM | Clearside Biomedical (Filer)
| Form EFFECT | |
05/11/2023
6:15 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
7:42 AM | Clearside Biomedical (Filer)
| Form DEFA14A | |
04/28/2023
7:36 AM | Clearside Biomedical (Filer)
| Form DEF 14A | |
04/18/2023
6:15 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
